337 related articles for article (PubMed ID: 33902624)
21. Effects of alpha-7 nicotinic allosteric modulator PNU 120596 on depressive-like behavior after lipopolysaccharide administration in mice.
Alzarea S; Rahman S
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():218-228. PubMed ID: 29800595
[TBL] [Abstract][Full Text] [Related]
22. The α7 nicotinic acetylcholine receptor positive allosteric modulator attenuates lipopolysaccharide-induced activation of hippocampal IκB and CD11b gene expression in mice.
Abbas M; Alzarea S; Papke RL; Rahman S
Drug Discov Ther; 2017; 11(4):206-211. PubMed ID: 28867753
[TBL] [Abstract][Full Text] [Related]
23. Activation of α7 Nicotinic Acetylcholine Receptor Upregulates HLA-DR and Macrophage Receptors: Potential Role in Adaptive Immunity and in Preventing Immunosuppression.
Siniavin AE; Streltsova MA; Kudryavtsev DS; Shelukhina IV; Utkin YN; Tsetlin VI
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32230846
[TBL] [Abstract][Full Text] [Related]
24. Interleukin 2 Ameliorates Autoimmune Neuroinflammation by Modulating the Balance of T Helper 17 Cells and Regulatory T Cells in Mouse.
Li J; Zhang Z; Du S; Guo Q
Ann Clin Lab Sci; 2021 Jul; 51(4):529-534. PubMed ID: 34452891
[TBL] [Abstract][Full Text] [Related]
25. Central Activation of Alpha7 Nicotinic Signaling Attenuates LPS-Induced Neuroinflammation and Sickness Behavior in Adult but Not in Aged Animals.
Navarro E; Norden DM; Trojanowski PJ; Godbout JP; López MG
Molecules; 2021 Apr; 26(8):. PubMed ID: 33916910
[TBL] [Abstract][Full Text] [Related]
26. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
[TBL] [Abstract][Full Text] [Related]
27. Allosterically Potentiated
Miller DR; Khoshbouei H; Garai S; Cantwell LN; Stokes C; Thakur G; Papke RL
Mol Pharmacol; 2020 Dec; 98(6):695-709. PubMed ID: 33020143
[TBL] [Abstract][Full Text] [Related]
28. LL-00066471, a novel positive allosteric modulator of α7 nicotinic acetylcholine receptor ameliorates cognitive and sensorimotor gating deficits in animal models: Discovery and preclinical characterization.
Verma MK; Goel RN; Bokare AM; Dandekar MP; Koul S; Desai S; Tota S; Singh N; Nigade PB; Patil VB; Modi D; Mehta M; Gundu J; Walunj SS; Karche NP; Sinha N; Kamboj RK; Palle VP
Eur J Pharmacol; 2021 Jan; 891():173685. PubMed ID: 33127363
[TBL] [Abstract][Full Text] [Related]
29. JWX-A0108, a positive allosteric modulator of α7 nAChR, attenuates cognitive deficits in APP/PS1 mice by suppressing NF-κB-mediated inflammation.
Li H; Gao J; Chang Y; Li K; Wang L; Ju C; Zhang F
Int Immunopharmacol; 2021 Jul; 96():107726. PubMed ID: 33975230
[TBL] [Abstract][Full Text] [Related]
30. Activating α7 nicotinic acetylcholine receptor inhibits NLRP3 inflammasome through regulation of β-arrestin-1.
Ke P; Shao BZ; Xu ZQ; Chen XW; Wei W; Liu C
CNS Neurosci Ther; 2017 Nov; 23(11):875-884. PubMed ID: 28941191
[TBL] [Abstract][Full Text] [Related]
31. Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration.
Ferrara G; Benzi A; Sturla L; Marubbi D; Frumento D; Spinelli S; Abbotto E; Ivaldi F; von Holtey M; Murone M; Nencioni A; Uccelli A; Bruzzone S
J Neuroinflammation; 2020 Jul; 17(1):228. PubMed ID: 32736564
[TBL] [Abstract][Full Text] [Related]
32. Expeditious synthesis, enantiomeric resolution, and enantiomer functional characterization of (4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (4BP-TQS): an allosteric agonist-positive allosteric modulator of α7 nicotinic acetylcholine receptors.
Thakur GA; Kulkarni AR; Deschamps JR; Papke RL
J Med Chem; 2013 Nov; 56(21):8943-7. PubMed ID: 24090443
[TBL] [Abstract][Full Text] [Related]
33. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling.
Zhang D; Qiao L; Fu T
Biomed Pharmacother; 2020 May; 125():109528. PubMed ID: 32106388
[TBL] [Abstract][Full Text] [Related]
34. GTS-21 attenuates lipopolysaccharide-induced inflammatory cytokine production in vitro by modulating the Akt and NF-κB signaling pathway through the α7 nicotinic acetylcholine receptor.
Yue Y; Liu R; Cheng W; Hu Y; Li J; Pan X; Peng J; Zhang P
Int Immunopharmacol; 2015 Dec; 29(2):504-512. PubMed ID: 26490221
[TBL] [Abstract][Full Text] [Related]
35. RIC3, the cholinergic anti-inflammatory pathway, and neuroinflammation.
Ben-David Y; Kagan S; Cohen Ben-Ami H; Rostami J; Mizrahi T; Kulkarni AR; Thakur GA; Vaknin-Dembinsky A; Healy LM; Brenner T; Treinin M
Int Immunopharmacol; 2020 Jun; 83():106381. PubMed ID: 32179243
[TBL] [Abstract][Full Text] [Related]
36. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
37. Effects of alpha-7 nicotinic acetylcholine receptor positive allosteric modulator on lipopolysaccharide-induced neuroinflammatory pain in mice.
Abbas M; Rahman S
Eur J Pharmacol; 2016 Jul; 783():85-91. PubMed ID: 27154173
[TBL] [Abstract][Full Text] [Related]
38. Agonist activation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.
Gill JK; Savolainen M; Young GT; Zwart R; Sher E; Millar NS
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5867-72. PubMed ID: 21436053
[TBL] [Abstract][Full Text] [Related]
39. Expression and Functional Role of α7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells.
Zanetti SR; Ziblat A; Torres NI; Zwirner NW; Bouzat C
J Biol Chem; 2016 Aug; 291(32):16541-52. PubMed ID: 27284006
[TBL] [Abstract][Full Text] [Related]
40. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
